Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank79
3Y CAGR-20.7%
5Y CAGR-34.3%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-20.7%/yr
Annual compound
5Y CAGR
-34.3%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 12.84% |
| 2024 | 40.04% |
| 2023 | -64.53% |
| 2022 | 25.76% |
| 2021 | -2006.52% |
| 2020 | 104.90% |
| 2019 | -13.93% |
| 2018 | -78.90% |
| 2017 | -0.21% |
| 2016 | -63.76% |